{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:09:25Z","timestamp":1790291365883,"version":"4.1.0"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"44","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1097\/md.0000000000001935","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T18:29:13Z","timestamp":1446575353000},"page":"e1935","source":"Crossref","is-referenced-by-count":25,"title":["Cardiometabolic Risk Profiles in Patients With Impaired Fasting Glucose and\/or Hemoglobin A1c 5.7% to 6.4%"],"prefix":"10.1097","volume":"94","author":[{"given":"Carolina","family":"Gir\u00e1ldez-Garc\u00eda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Javier","family":"Sangr\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"D\u00edaz-Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Franch-Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"D\u00edez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Buil-Cosiales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. Javier","family":"Garc\u00eda-Soid\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Artola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patxi","family":"Ezkurra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Manuel","family":"Millaruelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateu","family":"Segu\u00ed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Mart\u00ednez-Candela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Goday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Regidor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-39-20210226","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2337\/dc11-S011","article-title":"Standards of medical care in diabetes: 2011.","volume":"34","year":"2011","journal-title":"Diabetes Care"},{"key":"R2-39-20210226","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1001\/archinte.164.19.2147","article-title":"Is nondiabetic hyperglycemia a risk factor for cardiovascular disease A meta-analysis of prospective studies.","volume":"164","author":"Levitan","year":"2004","journal-title":"Arch Intern Med"},{"key":"R3-39-20210226","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0908359","article-title":"Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults.","volume":"362","author":"Selvin","year":"2010","journal-title":"N Engl J Med"},{"key":"R4-39-20210226","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome.","volume":"24","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"R5-39-20210226","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.numecd.2010.03.006","article-title":"Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.","volume":"21","author":"Bianchi","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"R6-39-20210226","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/jdi.12075","article-title":"Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness.","volume":"4","author":"Shin","year":"2013","journal-title":"J Diabetes Investig"},{"key":"R7-39-20210226","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2337\/dc06-0942","article-title":"The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey.","volume":"29","author":"Bonadonna","year":"2006","journal-title":"Diabetes Care"},{"key":"R8-39-20210226","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2337\/diacare.26.3.881","article-title":"Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA1c.","volume":"26","author":"Monnier","year":"2003","journal-title":"Diabetes Care"},{"key":"R9-39-20210226","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2337\/dc10-1314","article-title":"Implications of alternative definitions of prediabetes for prevalence in U.S. adults.","volume":"34","author":"James","year":"2011","journal-title":"Diabetes Care"},{"key":"R10-39-20210226","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.2337\/diacare.28.10.2388","article-title":"Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study.","volume":"28","author":"Novoa","year":"2005","journal-title":"Diabetes Care"},{"key":"R11-39-20210226","doi-asserted-by":"crossref","first-page":"278","DOI":"10.2337\/diacare.23.3.278","article-title":"Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report.","volume":"23","author":"Lim","year":"2000","journal-title":"Diabetes Care"},{"key":"R12-39-20210226","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.2337\/diabetes.48.11.2197","article-title":"Metabolic characteristics of individuals with impaired fasting glucose andor impaired glucose tolerance.","volume":"48","author":"Weyer","year":"1999","journal-title":"Diabetes"},{"key":"R13-39-20210226","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000294752","article-title":"People with impaired glucose tolerance and impaired fasting glucose are similarly susceptible to cardiovascular disease: a study in first-degree relatives of type 2 diabetic patients.","volume":"56","author":"Amini","year":"2010","journal-title":"Ann Nutr Metab"},{"key":"R14-39-20210226","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2337\/dc11-2032","article-title":"Cardiometabolic risk profiles and carotid atherosclerosis in individuals with prediabetes identified by fasting glucose, postchallenge glucose, and hemoglobin A1c criteria.","volume":"35","author":"Marini","year":"2012","journal-title":"Diabetes Care"},{"key":"R15-39-20210226","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4321\/S1135-57272013000200003","article-title":"Cohort study in primary health care on the evolution of patients with prediabetes (PREDAPS): basis and methodology.","volume":"87","author":"Serrano","year":"2013","journal-title":"Rev Esp Salud Publica"},{"key":"R16-39-20210226","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"R17-39-20210226","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","article-title":"National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification.","volume":"139","author":"Levey","year":"2003","journal-title":"Ann Intern Med"},{"key":"R18-39-20210226","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","article-title":"Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity.","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"R19-39-20210226","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.2337\/dc10-0752","article-title":"Impact of A1C screening criterion on the diagnosis of pre-diabetes among U.S. adults.","volume":"33","author":"Mann","year":"2010","journal-title":"Diabetes Care"},{"key":"R20-39-20210226","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(11)60472-8","article-title":"HbA1c 5.7-6.4 and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study.","volume":"378","author":"Heianza","year":"2011","journal-title":"Lancet"},{"key":"R21-39-20210226","doi-asserted-by":"crossref","first-page":"5289","DOI":"10.1210\/jc.2010-1171","article-title":"Identifying dysglycemic states in older adults: implications of the emerging use of hemoglobin A1c.","volume":"95","author":"Lipska","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"R22-39-20210226","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.amjcard.2006.04.046","article-title":"Metabolic syndrome and hyperglycemia: congruence and divergence.","volume":"98","author":"Alexander","year":"2006","journal-title":"Am J Cardiol"},{"key":"R23-39-20210226","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.2337\/dc11-0183","article-title":"Limited overlap between intermediate hyperglycemia as defined by A1C 5.7-6.4, impaired fasting glucose, and impaired glucose tolerance.","volume":"34","author":"Saukkonen","year":"2011","journal-title":"Diabetes Care"},{"key":"R24-39-20210226","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/jhh.2014.77","article-title":"Fasting glucose and HbA1c levels as risk factors for the development of hypertension in Japanese individuals: Toranomon hospital health management center study 16 (TOPICS 16).","volume":"29","author":"Heianza","year":"2015","journal-title":"J Human Hypertens"},{"key":"R25-39-20210226","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.diabres.2011.10.012","article-title":"Usefulness of hemoglobin A1c as a criterion of dysglycemia in the definition of metabolic syndrome in Koreans.","volume":"95","author":"Kim","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"R26-39-20210226","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.dsx.2012.09.011","article-title":"Comparison of glycated hemoglobin with fasting plasma glucose in definition of glycemic component of the metabolic syndrome in an Iranian population.","volume":"6","author":"Janghorbani","year":"2012","journal-title":"Diabetes Metab Syndr"},{"key":"R27-39-20210226","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.2337\/dc10-0190","article-title":"Using glycosylated hemoglobin to define the metabolic syndrome in United States adults.","volume":"33","author":"Ong","year":"2010","journal-title":"Diabetes Care"},{"key":"R28-39-20210226","doi-asserted-by":"crossref","first-page":"e0134154","DOI":"10.1371\/journal.pone.0134154","article-title":"HbA1c alone is a poor indicator of cardiometabolic risk in middle-aged subjects with pre-diabetes but is suitable for type 2 diabetes diagnosis: a cross-sectional study.","volume":"10","author":"Millar","year":"2015","journal-title":"PLoS One"},{"key":"R29-39-20210226","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archinte.167.14.1545","article-title":"Short-term variability in measures of glycemia and implications for the classification of diabetes.","volume":"167","author":"Selvin","year":"2007","journal-title":"Arch Intern Med"},{"key":"R30-39-20210226","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1186\/1471-2458-13-1045","article-title":"Impact of HbA1c criterion on the definition of glycemic component of the metabolic syndrome: The China health and nutrition survey 2009.","volume":"13","author":"Sun","year":"2013","journal-title":"BMC Public Health"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000001935","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:53:17Z","timestamp":1620960797000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201511030-00039"}},"subtitle":["Evidence for a Gradient According to Diagnostic Criteria The PREDAPS Study"],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":30,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000001935","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}